Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid
A forum for researchers, students and applicants in the field of cyclodextrin technology
A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid
CDs and their inclusion complexes have been proposed to be used as potential allies in food packaging, especially in active
The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects more than 10 million people worldwide. Oxidative stress and mitochondrial
In previous studies, the extraction of mycotoxins alternariol, zearalenone, zearalenols, zearalenone-14-glucoside, and zearalenone-14-sulfate from aqueous solutions (including certain beverages) by
A recently published patent of Union Therapeutics, Denmark (US11045434) (granted extremely rapidly by USPTO within 8 months from filing date)
A study recently published in the Journal of Functional Foods shows that ingestion of the curcumin-cyclodextrin complex CAVACURMIN® leads to an
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
CycloLab celebrates birthday of L. Szente (70), former CEO Lajos Szente has been contributing to the development of the global
Cyclolab, a company with unparalleled expertise in the manufacturing, design and formulation of cyclodextrins, announced the appointment of Tamas Sohajda